Parkwalk Advisors's Health Care Portfolio

NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market.

Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.

Natrox is a wound care company that offers innovative technologies for healthcare professionals for chronic wounds.

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

Koalaa offers comfy, soft prosthetic arms and personalized support, for babies, kids, and adults.

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Visible warning of bacterial infection in packaging.

Entia is a medical technology company that specializes in improving access to blood test.

Echopoint Medical is a medtech company

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

gaitQ® develops innovative wearable technology that improves people’s mobility and quality of life.

Adsilico redefines medical device innovation.

A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.

Xerion Healthcare is the technology commercialization company of University of Oxford.

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

PetMedix is a pet therapeutics startup.

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.